Compare ARK Genomic Revolution ETF (ARKG) vs Alibaba Group (BABA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Alibaba Group — how do they compare? ARK Genomic Revolution ETF trades at $40.91, while Alibaba Group trades at $114.07 (market cap $269.48B). The key difference: Alibaba Group pays a 0.93% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Alibaba Group nearer its low. Which is the better fit depends on your goals.
| ARKG | BABA | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $189.34 |
52-Week Low | $23.09 | $94.83 |
Market Cap | — | $269.48B |
Volume | — | 18,069,938 |
Enterprise Value | — | $264.31B |
Dividend Yield | — | 0.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Alibaba (BABA) trades at $112.33, up 1.07% today, with a bullish technical signal and strong analyst consensus. Recent earnings misses contrast with improving fundamentals, including a 13.05% net margin and $130.11B net income for 2025. The stock faces headwinds from securities investigations but benefits from AI momentum and narrowing losses in quick commerce.
Outlook remains positive with an 86% buy rating and $195 consensus target, though risks include regulatory scrutiny and earnings volatility. Upside potential hinges on execution in cloud and e-commerce, while legal overhangs and macroeconomic pressures pose near-term challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →
